4.5 Letter

Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit

Journal

PIGMENT CELL & MELANOMA RESEARCH
Volume 30, Issue 3, Pages 378-380

Publisher

WILEY
DOI: 10.1111/pcmr.12576

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available